CliffBio
biologic

T.R.U.E. Test

Thin-Layer Rapid Use Epicutaneous Patch Test

Loss of exclusivityAugust 2009projected — 12-year biologic exclusivity estimate
CompanySmartpractice Denmark Aps →See this company's full patent-cliff portfolio

Drug detail

Brand nameT.R.U.E. Test
Active ingredientThin-Layer Rapid Use Epicutaneous Patch Test
Strength36 MCG NICKEL/PATCH, 810 MCG WOOL ALCOHOL/PATCH, 486 MCG NEOMYCIN SULFATE/PATCH, 15.7 MCG CHROMIUM/PATCH, 510 MCG CAINE MIX/PATCH, 405 MCG FRAGRANCE MIX/PATCH, 972 MCG COLOPHONY/PATCH, 810 MCG PARABEN/PATCH, 648 MCG OF BALSAM OF PERU RESIN/PATCH, 18 MCG E
Dosage formPatch
RouteTopical
ModalityBiologic
FDA approvalAugust 1997
Marketing statusRx

More from Smartpractice Denmark Aps

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

T.R.U.E. Test patent cliff — loss of exclusivity August 2009 | CliffBio